The RBE-weighted absorbed dose, called “biological dose, ” has been routinely used for carbon-ion treatment planning in Japan to formulate dose prescriptions for treatment protocols. This paper presents a microdosimetric approach to measuring the biological dose, which was redefined to be derived from microdosimetric quantities measured by a tissue-equivalent proportional counter (TEPC). The TEPC was calibrated in 60Co gamma rays to assure a traceability of the TEPC measurement to Japanese standards and to eliminate the discrepancies among matching counters. The absorbed doses measured by the TEPC were reasonably coincident with those measured by a reference ionization chamber. The RBE value was calculated from the microdosimetric spectrum ...
Background and purpose: In carbon ion radiotherapy (CIRT), the use of different relative biological ...
Microdosimetry with the microdosimetric kinetic (MK) model is a method to estimate the biological ef...
Purpose: Positive outcomes of carbon-ion and proton radiotherapies extend patients\u27 lives and all...
The RBE-weighted absorbed dose, called "biological dose", has been routinely used for carbon-ion tre...
Carbon therapy is increasing worldwide for treating some radioresistant tumours due to its better co...
Due to the RBE variations, the carbon-ion doses (in Gy) are no longer sufficient to monitor adequate...
The clinical dose distributions of therapeutic carbon beams, currently used at NIRS HIMAC, are based...
We developed a calculation technique to evaluate the biological dose distribution of heavy ion beams...
At the National Institute of Radiological Sciences (NIRS), more than 8,000 patients have been treate...
Escalating relative biological effectiveness (RBE) of carbon-ion beam toward range end is attractive...
Radiation therapy with protons and ions is gaining popularity all over the world, because of the phy...
Cerebral radionecrosis is a significant side effect in radiotherapy for brain cancer. The purpose of...
In carbon ion radiotherapy there is an urgent clinical need to develop objective tools for the conve...
Particle therapy facilities often require Monte Carlo (MC) simulations to overcome intrinsic limitat...
In carbon ion radiotherapy there is an urgent clinical need to develop objectivetools for the conver...
Background and purpose: In carbon ion radiotherapy (CIRT), the use of different relative biological ...
Microdosimetry with the microdosimetric kinetic (MK) model is a method to estimate the biological ef...
Purpose: Positive outcomes of carbon-ion and proton radiotherapies extend patients\u27 lives and all...
The RBE-weighted absorbed dose, called "biological dose", has been routinely used for carbon-ion tre...
Carbon therapy is increasing worldwide for treating some radioresistant tumours due to its better co...
Due to the RBE variations, the carbon-ion doses (in Gy) are no longer sufficient to monitor adequate...
The clinical dose distributions of therapeutic carbon beams, currently used at NIRS HIMAC, are based...
We developed a calculation technique to evaluate the biological dose distribution of heavy ion beams...
At the National Institute of Radiological Sciences (NIRS), more than 8,000 patients have been treate...
Escalating relative biological effectiveness (RBE) of carbon-ion beam toward range end is attractive...
Radiation therapy with protons and ions is gaining popularity all over the world, because of the phy...
Cerebral radionecrosis is a significant side effect in radiotherapy for brain cancer. The purpose of...
In carbon ion radiotherapy there is an urgent clinical need to develop objective tools for the conve...
Particle therapy facilities often require Monte Carlo (MC) simulations to overcome intrinsic limitat...
In carbon ion radiotherapy there is an urgent clinical need to develop objectivetools for the conver...
Background and purpose: In carbon ion radiotherapy (CIRT), the use of different relative biological ...
Microdosimetry with the microdosimetric kinetic (MK) model is a method to estimate the biological ef...
Purpose: Positive outcomes of carbon-ion and proton radiotherapies extend patients\u27 lives and all...